1-MONTH TREATMENT WITH ELUXADOLINE FOR IBS-D PREDICTS SUSTAINED RESPONSE: CONTINUATION ANALYSES OF RESPONSE IN TWO PHASE 3 STUDIES
William D. Chey 1
David A. Andrae 2
Leonard S. Dove 3
Catherine R. Gutman 2
Paul S. Covington 4
1 University of Michigan, Ann Arbor, United States of America
2 Allergan plc, Jersey City, United States of America
3 Former employee of FuriePharmaceuticals, an Allergan affiliate, Jersey City, United States of America
4 Former employee of FuriePharmaceuticals, an Allergan affiliate, Jer
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing